EP1066040A1 — Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
Assigned to Daewoong Pharmaceutical Co Ltd · Expires 2001-01-10 · 25y expired
What this patent protects
The present invention relates to a pharmaceutical composition containing cefuroxine axetil wherein the active ingredient is not gelled by moisture absorption and is thus stable during storage period. More specifically, the present invention relates to a pharmaceutical composition…
USPTO Abstract
The present invention relates to a pharmaceutical composition containing cefuroxine axetil wherein the active ingredient is not gelled by moisture absorption and is thus stable during storage period. More specifically, the present invention relates to a pharmaceutical composition which comprises amorphous cefuroxime axetil as an active ingredient and silicon dioxide or its hydrate as a micro-environmental pH adjustor and an anti-gelling agent for cefuroxime axetil. The composition according to the present invention can be provided in the oral formulation such as tablets, capsules, granules, powders and dry syrups.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.